(HealthDay)—Treatment with bamlanivimab and etesevimab, but not monotherapy with bamlanivimab, is associated with a reduction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load in […]
Many college students fully recover from infectious mononucleosis (which is almost always caused by Epstein-Barr virus) within 1-6 weeks, but some go on to develop chronic […]
There is some evidence that a new coronavirus variant first identified in southeast England carries a higher risk of death .than the original strain, the British […]
The COVID-19 pandemic slackened its pace around the world over the past week, but Latin America and the Caribbean saw a fresh surge, according to a […]